Academic Journal
Alcohol Use Disorder versus Adverse In-Hospital Outcomes after Radical Cystectomy and Ileal Conduit Urinary Diversion.
| Title: | Alcohol Use Disorder versus Adverse In-Hospital Outcomes after Radical Cystectomy and Ileal Conduit Urinary Diversion. |
|---|---|
| Authors: | Polverino F; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada. fedepolve97@gmail.com.; Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy. fedepolve97@gmail.com., Catanzaro C; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.; Division of Urology, IRCCS Azienda Ospedaliero-universitaria di Bologna, Bologna, Italy., Nicolazzini M; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.; Division of Urology, Department of Translational Medicine, University of Eastern Piedmont, Maggiore della Carità Hospital, Novara, Italy., Petix M; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.; Università degli Studi di Milano, Milan, Italy., Quarta L; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.; Vita-Salute San Raffaele University, Milan, Italy.; Division of Experimental Oncology/Unit of Urology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy., Filzmayer M; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.; Department of Urology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany., Goyal JA; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada., Morra S; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.; Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy., Califano G; Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy., Collà Ruvolo C; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.; Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy., La Rocca R; Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy., Briganti A; Vita-Salute San Raffaele University, Milan, Italy.; Division of Experimental Oncology/Unit of Urology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy., Chun FKH; Department of Urology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany., Palumbo C; Division of Urology, Department of Translational Medicine, University of Eastern Piedmont, Maggiore della Carità Hospital, Novara, Italy., Schiavina R; Division of Urology, IRCCS Azienda Ospedaliero-universitaria di Bologna, Bologna, Italy., Musi G; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.; Università degli Studi di Milano, Milan, Italy., Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, Weill Cornell Medical College, New York, NY, USA.; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.; Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan., Saad F; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada., Longo N; Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy., Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada. |
| Source: | Annals of surgical oncology [Ann Surg Oncol] 2026 Jun; Vol. 33 (6), pp. 5847-5853. Date of Electronic Publication: 2026 Jan 12. |
| Publication Type: | Journal Article |
| Language: | English |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE |
| Imprint Name(s): | Publication: 2005- : New York, NY : Springer Original Publication: New York, NY : Raven Press, c1994- |
| MeSH Terms: | Cystectomy*/adverse effects , Cystectomy*/mortality , Urinary Diversion*/adverse effects , Urinary Diversion*/mortality , Urinary Bladder Neoplasms*/surgery , Urinary Bladder Neoplasms*/pathology , Postoperative Complications*/etiology , Alcoholism*/complications, Length of Stay/statistics & numerical data ; Humans ; Female ; Male ; Hospital Mortality ; Aged ; Middle Aged ; Prognosis ; Survival Rate ; Follow-Up Studies |
| Abstract: | Background: Radical cystectomy (RC) is the gold standard treatment for muscle-invasive bladder cancer (BCa). Alcohol use disorder (AUD) may predispose to worse adverse in-hospital outcomes after RC and ileal conduit urinary diversion. The current study addressed this knowledge gap. Patients and Methods: Descriptive analyses, propensity score matching (PSM), and multivariable logistic and Poisson regression models were used to address patients with BCa treated with RC and ileal conduit within National Inpatient Sample (2006-2019). Results: Of 15,018 RC and ileal conduit patients, 320 (2.1%) had history of AUD at baseline. Compared with their non-AUD counterparts, patients with AUD exhibited significantly higher rates of adverse in-hospital outcomes in 9 of 14 categories, namely: critical care therapies (Δ + 12.0%), overall complications (Δ + 11.0%), prolonged length of stay (Δ + 11.0%), pulmonary complications (Δ + 6.0%), acute kidney injury (Δ + 5.0%), hepatic complications (Δ + 3.2%), in-hospital mortality (Δ + 2.8%), cardiac complications (Δ + 1.6%), and total hospital charges (Δ + 7925 US$, all p < 0.05). After multivariable adjustment, AUD independently predicted higher rates of adverse in-hospital outcomes in the same 9 of 15 categories, namely: hepatic complications [odds ratio (OR) 3.3], in-hospital mortality (OR 3.2), acute kidney injury (OR 1.7), overall complications (OR 1.7), cardiac complications (OR 1.5), critical care therapies (OR 1.4), prolonged length of stay (OR 1.3), pulmonary complications (OR 1.2), and total hospital charges (OR 1.2, all p < 0.01). Conclusions: Since AUD significantly predisposes to higher rates of adverse in-hospital outcomes and in-hospital mortality after RC and ileal conduit urinary diversion, precautionary measures prior to admission and during hospital stay may be warranted in patients with AUD. (© 2026. Society of Surgical Oncology.) |
| Competing Interests: | Disclosure: The authors have nothing to report. |
| References: | Alcohol [Internet]. [citato 1 maggio 2025]. Disponibile su: https://www.who.int/health-topics/alcohol. Epidemiology of alcohol use disorder: understanding prevalence, trends, and public health implications - DoveMed [Internet]. [citato 28 maggio 2025]. Disponibile su: https://www.dovemed.com/health-topics/focused-health-topics/epidemiology-alcohol-use-disorder-understanding-prevalence-trends-and-public-health-implications. EAU Guidelines - Uroweb [Internet]. [citato 12 maggio 2025]. Disponibile su: https://uroweb.org/guidelines/muscle-invasive-and-metastatic-bladder-cancer. Nicolazzini M, Rodriguez Peñaranda N, Falkenbach F, Longoni M, Marmiroli A, Le QC, et al. The effect of chronic kidney disease on adverse in-hospital outcomes after radical cystectomy with ileal conduit urinary diversion. World J Urol. 2025;43(1):149. (PMID: 10.1007/s00345-025-05496-640044881) Deuker M, Stolzenbach LF, Collà Ruvolo C, Nocera L, Mansour M, Tian Z, et al. Obesity is associated with adverse short-term perioperative outcomes in patients treated with open and robot-assisted radical cystectomy for bladder cancer. Urol Oncol Semin Orig Investig [Internet]. 1 gennaio 2021 [citato 7 maggio 2025];39(1):75.e17-75.e25. Disponibile su: https://www.sciencedirect.com/science/article/pii/S107814392030291X. Angus R, Leow TW, Humes D, Adiamah A. The relationship between alcohol consumption and outcomes after gastrointestinal surgery: a systematic review and meta-analysis. Alcohol Alcohol Oxf Oxf [Internet]. 5 febbraio 2025 [citato 1 maggio 2025];60(2):agaf002. Disponibile su: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11794451/. Rolfzen ML, Mikulich-Gilbertson SK, Natvig C, Carrico JA, Lobato RL, Krause M, et al. Association between alcohol use disorder and hospital outcomes in colectomy patients - A retrospective cohort study. J Clin Anesth giugno. 2022;78:110674. (PMID: 10.1016/j.jclinane.2022.110674) Khan AMA, Soliman MAR, Quiceno E, Elbayomy AM, Malueg MD, Aguirre AO, et al. Association of alcohol use disorder and perioperative complications and adverse events after spinal fusion surgery during the in-hospital period: an analysis of the National Inpatient Sample Database. World Neurosurg [Internet]. 1 marzo 2025 [citato 27 maggio 2025];195:123677. Disponibile su: https://www.sciencedirect.com/science/article/pii/S1878875025000233. Li R, Huddleston SJ, Prastein DJ. Alcohol use disorder is associated with a lower risk of in-hospital mortality in type A aortic dissection repair: a population-based study of National Inpatient Sample from 2015–2020. Alcohol Alcohol Oxf Oxf. 2024;59(5):agae061. (PMID: 10.1093/alcalc/agae061) National (Nationwide) Inpatient Sample (NIS) [Internet]. [citato 26 febbraio 2025]. Disponibile su: https://hcup-us.ahrq.gov/news/exhibit_booth/nis_brochure.jsp. Di Bello F, Rodriguez Peñaranda N, Marmiroli A, Longoni M, Falkenbach F, Le Chi Q, et al. Robot-assisted versus open radical cystectomy: comparison of adverse in-hospital outcomes. J Surg Oncol. 2025;131(8):1651–60. (PMID: 10.1002/jso.2810840152714) Polverino F, Marmiroli A, Longoni M, Le QC, Falkenbach F, Nicolazzini M, et al. The effect of chronic liver disease on adverse in-hospital outcomes after radical cystectomy and ileal conduit urinary diversion. Ann Surg Oncol. 2025. https://doi.org/10.1245/s10434-025-18032-y . (PMID: 10.1245/s10434-025-18032-y41339563) Di Bello F, Siech C, de Angelis M, Rodriguez Peñaranda N, Tian Z, Goyal JA, et al. Perioperative complications and in-hospital mortality in paraplegic radical cystectomy patients. Ann Surg Oncol. 2025;32(1):583–8. (PMID: 10.1245/s10434-024-16332-339377845) Mazzone E, Preisser F, Nazzani S, Tian Z, Zaffuto E, Gallina A, et al. The effect of age and comorbidities on early postoperative complications after radical cystectomy: a contemporary population-based analysis. J Geriatr Oncol. 2019;10(4):623–31. (PMID: 10.1016/j.jgo.2019.04.01131010691) Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–9. (PMID: 10.1016/0895-4356(92)90133-81607900) Siech C, Baudo A, de Angelis M, Jannello LMI, Di Bello F, Goyal JA, et al. Perioperative complications and in-hospital mortality in radical cystectomy patients with heart-valve replacement. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2024;50(6):108297. Rodriguez Peñaranda N, Falkenbach F, Marmiroli A, Longoni M, Le QC, Catanzaro C, et al. Contemporary rates and predictors of prolonged hospital stay after radical cystectomy: a population-based analysis. World J Urol. 2025;43(1):478. (PMID: 10.1007/s00345-025-05860-640778945) World Health Organization (WHO) [Internet]. [citato 28 maggio 2025]. Disponibile su: https://www.who.int/. Schulz KF, Grimes DA. Case-control studies: research in reverse. Lancet Lond Engl. 2002;359(9304):431–4. (PMID: 10.1016/S0140-6736(02)07605-5) Desai RJ, Franklin JM. Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners. BMJ. 2019;367:l5657. (PMID: 10.1136/bmj.l565731645336) Lane O, Ambai V, Bakshi A, Potru S. Alcohol use disorder in the perioperative period: a summary and recommendations for anesthesiologists and pain physicians. Reg Anesth Pain Med. 2024;49(9):621–7. (PMID: 10.1136/rapm-2023-10435438050177) Sander M, Neumann T, von Dossow V, Schönfeld H, Lau A, Eggers V, et al. Alcohol use disorder: risks in anesthesia and intensive care medicine. Internist. 2006;47(4):332, 334–332336. (PMID: 16521004) Watzl B, Watson RR. Role of alcohol abuse in nutritional immunosuppression. J Nutr. 1992;122(3 Suppl):733–7. (PMID: 10.1093/jn/122.suppl_3.7331542040) Jaan A, Razzak IA, Chaudhary AJ, Farooq U, Khan AM, Sheikh LF, et al. Malnutrition severity predicts clinical outcomes in alcoholic hepatitis: evidence from national data. J Am Nutr Assoc. 2025;44(1):22–8. (PMID: 39073449) Lauridsen SV, Thomsen T, Jensen JB, Kallemose T, Schmidt Behrend M, Steffensen K, et al. Effect of a smoking and alcohol cessation intervention initiated shortly before radical cystectomy-The STOP-OP study: a randomised clinical trial. Eur Urol Focus. 2022;8(6):1650–8. (PMID: 10.1016/j.euf.2022.02.00535241394) Egholm JW, Pedersen B, Møller AM, Adami J, Juhl CB, Tønnesen H. Perioperative alcohol cessation intervention for postoperative complications. Cochrane Database Syst Rev. 2018;11(11):18343. Morra S, Scheipner L, Baudo A, Jannello LMI, de Angelis M, Siech C, et al. Contemporary conditional cancer-specific survival rates in surgically treated nonmetastatic primary urethral carcinoma. J Surg Oncol. 2024;129(7):1348–53. (PMID: 10.1002/jso.2763738606531) Morra S, Scheipner L, Baudo A, Jannello LMI, de Angelis M, Siech C, et al. Unmarried status effect on stage at presentation and treatment patterns in primary urethral carcinoma patients. Urol Oncol. 2024;42(5):161.e17-161.e23. (PMID: 10.1016/j.urolonc.2024.01.02238320935) Nicolazzini M, Longoni M, Falkenbach F, Marmiroli A, Le QC, Catanzaro C, et al. Extracorporeal vs. intracorporeal urinary diversion at robot-assisted radical cystectomy: adverse in-hospital outcomes. J Robot Surg. 2025;19(1):351. (PMID: 10.1007/s11701-025-02512-040616730) Di Bello F, Rodriguez Peñaranda N, Marmiroli A, Longoni M, Falkenbach F, Le QC, et al. Total hospital cost of robot-assisted approach in major urological cancer surgeries. Minerva Urol Nephrol. 2025;77(2):217–25. (PMID: 10.23736/S2724-6051.25.06282-240298347) Rodriguez Peñaranda N, di Bello F, Marmiroli A, Falkenbach F, Longoni M, Le QC, et al. Urinary diversion versus adverse in-hospital outcomes after radical cystectomy. Ann Surg Oncol. 2025;32(3):2233–40. (PMID: 10.1245/s10434-024-16644-439656392) |
| Contributed Indexing: | Keywords: Alcohol use disorder; Complications; Cystectomy; NIS; Urinary bladder cancer |
| Entry Date(s): | Date Created: 20260112 Date Completed: 20260626 Latest Revision: 20260626 |
| Update Code: | 20260626 |
| DOI: | 10.1245/s10434-025-19018-6 |
| PMID: | 41524880 |
| Database: | MEDLINE |
| FullText | Links: – Type: other Url: https://resolver.ebsco.com:443/public/rma-ftfapi/ejs/direct?AccessToken=45BC8BDA353BB317C24E&Show=Object Text: Availability: 0 CustomLinks: – Url: https://dx.doi.org/doi:10.1245/s10434-025-19018-6 Name: EDS - Springer Nature Journals (s7799221) Category: fullText Text: View record at Springer |
|---|---|
| Header | DbId: cmedm DbLabel: MEDLINE An: 41524880 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Alcohol Use Disorder versus Adverse In-Hospital Outcomes after Radical Cystectomy and Ileal Conduit Urinary Diversion. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Polverino+F%22">Polverino F</searchLink>; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada. fedepolve97@gmail.com.; Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy. fedepolve97@gmail.com.<br /><searchLink fieldCode="AU" term="%22Catanzaro+C%22">Catanzaro C</searchLink>; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.; Division of Urology, IRCCS Azienda Ospedaliero-universitaria di Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Nicolazzini+M%22">Nicolazzini M</searchLink>; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.; Division of Urology, Department of Translational Medicine, University of Eastern Piedmont, Maggiore della Carità Hospital, Novara, Italy.<br /><searchLink fieldCode="AU" term="%22Petix+M%22">Petix M</searchLink>; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.; Università degli Studi di Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Quarta+L%22">Quarta L</searchLink>; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.; Vita-Salute San Raffaele University, Milan, Italy.; Division of Experimental Oncology/Unit of Urology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Filzmayer+M%22">Filzmayer M</searchLink>; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.; Department of Urology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Goyal+JA%22">Goyal JA</searchLink>; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Morra+S%22">Morra S</searchLink>; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.; Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Califano+G%22">Califano G</searchLink>; Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Collà+Ruvolo+C%22">Collà Ruvolo C</searchLink>; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.; Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22La+Rocca+R%22">La Rocca R</searchLink>; Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Briganti+A%22">Briganti A</searchLink>; Vita-Salute San Raffaele University, Milan, Italy.; Division of Experimental Oncology/Unit of Urology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Chun+FKH%22">Chun FKH</searchLink>; Department of Urology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Palumbo+C%22">Palumbo C</searchLink>; Division of Urology, Department of Translational Medicine, University of Eastern Piedmont, Maggiore della Carità Hospital, Novara, Italy.<br /><searchLink fieldCode="AU" term="%22Schiavina+R%22">Schiavina R</searchLink>; Division of Urology, IRCCS Azienda Ospedaliero-universitaria di Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Musi+G%22">Musi G</searchLink>; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.; Università degli Studi di Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Shariat+SF%22">Shariat SF</searchLink>; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, Weill Cornell Medical College, New York, NY, USA.; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.; Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan.<br /><searchLink fieldCode="AU" term="%22Saad+F%22">Saad F</searchLink>; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Longo+N%22">Longo N</searchLink>; Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Karakiewicz+PI%22">Karakiewicz PI</searchLink>; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229420840%22">Annals of surgical oncology</searchLink> [Ann Surg Oncol] 2026 Jun; Vol. 33 (6), pp. 5847-5853. <i>Date of Electronic Publication: </i>2026 Jan 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: Language Label: Language Group: Lang Data: English – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9420840 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1534-4681 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210689265%22">10689265 </searchLink><i>NLM ISO Abbreviation: </i>Ann Surg Oncol <i>Subsets: </i>MEDLINE – Name: PublisherInfo Label: Imprint Name(s) Group: PubInfo Data: <i>Publication</i>: 2005- : New York, NY : Springer<br /><i>Original Publication</i>: New York, NY : Raven Press, c1994- – Name: SubjectMESH Label: MeSH Terms Group: Su Data: <searchLink fieldCode="MM" term="%22Cystectomy%22">Cystectomy*</searchLink>/<searchLink fieldCode="MM" term="%22Cystectomy+adverse+effects%22">adverse effects</searchLink> <br /><searchLink fieldCode="MM" term="%22Cystectomy%22">Cystectomy*</searchLink>/<searchLink fieldCode="MM" term="%22Cystectomy+mortality%22">mortality</searchLink> <br /><searchLink fieldCode="MM" term="%22Urinary+Diversion%22">Urinary Diversion*</searchLink>/<searchLink fieldCode="MM" term="%22Urinary+Diversion+adverse+effects%22">adverse effects</searchLink> <br /><searchLink fieldCode="MM" term="%22Urinary+Diversion%22">Urinary Diversion*</searchLink>/<searchLink fieldCode="MM" term="%22Urinary+Diversion+mortality%22">mortality</searchLink> <br /><searchLink fieldCode="MM" term="%22Urinary+Bladder+Neoplasms%22">Urinary Bladder Neoplasms*</searchLink>/<searchLink fieldCode="MM" term="%22Urinary+Bladder+Neoplasms+surgery%22">surgery</searchLink> <br /><searchLink fieldCode="MM" term="%22Urinary+Bladder+Neoplasms%22">Urinary Bladder Neoplasms*</searchLink>/<searchLink fieldCode="MM" term="%22Urinary+Bladder+Neoplasms+pathology%22">pathology</searchLink> <br /><searchLink fieldCode="MM" term="%22Postoperative+Complications%22">Postoperative Complications*</searchLink>/<searchLink fieldCode="MM" term="%22Postoperative+Complications+etiology%22">etiology</searchLink> <br /><searchLink fieldCode="MM" term="%22Alcoholism%22">Alcoholism*</searchLink>/<searchLink fieldCode="MM" term="%22Alcoholism+complications%22">complications</searchLink><br /><searchLink fieldCode="MH" term="%22Length+of+Stay%22">Length of Stay</searchLink>/<searchLink fieldCode="MH" term="%22Length+of+Stay+statistics+%26+numerical+data%22">statistics & numerical data</searchLink> ; <searchLink fieldCode="MH" term="%22Humans%22">Humans</searchLink> ; <searchLink fieldCode="MH" term="%22Female%22">Female</searchLink> ; <searchLink fieldCode="MH" term="%22Male%22">Male</searchLink> ; <searchLink fieldCode="MH" term="%22Hospital+Mortality%22">Hospital Mortality</searchLink> ; <searchLink fieldCode="MH" term="%22Aged%22">Aged</searchLink> ; <searchLink fieldCode="MH" term="%22Middle+Aged%22">Middle Aged</searchLink> ; <searchLink fieldCode="MH" term="%22Prognosis%22">Prognosis</searchLink> ; <searchLink fieldCode="MH" term="%22Survival+Rate%22">Survival Rate</searchLink> ; <searchLink fieldCode="MH" term="%22Follow-Up+Studies%22">Follow-Up Studies</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Background: Radical cystectomy (RC) is the gold standard treatment for muscle-invasive bladder cancer (BCa). Alcohol use disorder (AUD) may predispose to worse adverse in-hospital outcomes after RC and ileal conduit urinary diversion. The current study addressed this knowledge gap.<br />Patients and Methods: Descriptive analyses, propensity score matching (PSM), and multivariable logistic and Poisson regression models were used to address patients with BCa treated with RC and ileal conduit within National Inpatient Sample (2006-2019).<br />Results: Of 15,018 RC and ileal conduit patients, 320 (2.1%) had history of AUD at baseline. Compared with their non-AUD counterparts, patients with AUD exhibited significantly higher rates of adverse in-hospital outcomes in 9 of 14 categories, namely: critical care therapies (Δ + 12.0%), overall complications (Δ + 11.0%), prolonged length of stay (Δ + 11.0%), pulmonary complications (Δ + 6.0%), acute kidney injury (Δ + 5.0%), hepatic complications (Δ + 3.2%), in-hospital mortality (Δ + 2.8%), cardiac complications (Δ + 1.6%), and total hospital charges (Δ + 7925 US$, all p &lt; 0.05). After multivariable adjustment, AUD independently predicted higher rates of adverse in-hospital outcomes in the same 9 of 15 categories, namely: hepatic complications [odds ratio (OR) 3.3], in-hospital mortality (OR 3.2), acute kidney injury (OR 1.7), overall complications (OR 1.7), cardiac complications (OR 1.5), critical care therapies (OR 1.4), prolonged length of stay (OR 1.3), pulmonary complications (OR 1.2), and total hospital charges (OR 1.2, all p &lt; 0.01).<br />Conclusions: Since AUD significantly predisposes to higher rates of adverse in-hospital outcomes and in-hospital mortality after RC and ileal conduit urinary diversion, precautionary measures prior to admission and during hospital stay may be warranted in patients with AUD.<br /> (© 2026. Society of Surgical Oncology.) – Name: Abstract Label: Competing Interests Group: Ab Data: Disclosure: The authors have nothing to report. – Name: Ref Label: References Group: RefInfo Data: Alcohol [Internet]. [citato 1 maggio 2025]. Disponibile su: https://www.who.int/health-topics/alcohol.<br />Epidemiology of alcohol use disorder: understanding prevalence, trends, and public health implications - DoveMed [Internet]. [citato 28 maggio 2025]. Disponibile su: https://www.dovemed.com/health-topics/focused-health-topics/epidemiology-alcohol-use-disorder-understanding-prevalence-trends-and-public-health-implications.<br />EAU Guidelines - Uroweb [Internet]. [citato 12 maggio 2025]. Disponibile su: https://uroweb.org/guidelines/muscle-invasive-and-metastatic-bladder-cancer.<br />Nicolazzini M, Rodriguez Peñaranda N, Falkenbach F, Longoni M, Marmiroli A, Le QC, et al. The effect of chronic kidney disease on adverse in-hospital outcomes after radical cystectomy with ileal conduit urinary diversion. World J Urol. 2025;43(1):149. (PMID: <searchLink fieldCode="PM" term="%2210%2E1007%2Fs00345-025-05496-640044881%22">10.1007/s00345-025-05496-640044881)</searchLink><br />Deuker M, Stolzenbach LF, Collà Ruvolo C, Nocera L, Mansour M, Tian Z, et al. Obesity is associated with adverse short-term perioperative outcomes in patients treated with open and robot-assisted radical cystectomy for bladder cancer. Urol Oncol Semin Orig Investig [Internet]. 1 gennaio 2021 [citato 7 maggio 2025];39(1):75.e17-75.e25. Disponibile su: https://www.sciencedirect.com/science/article/pii/S107814392030291X.<br />Angus R, Leow TW, Humes D, Adiamah A. The relationship between alcohol consumption and outcomes after gastrointestinal surgery: a systematic review and meta-analysis. Alcohol Alcohol Oxf Oxf [Internet]. 5 febbraio 2025 [citato 1 maggio 2025];60(2):agaf002. Disponibile su: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11794451/.<br />Rolfzen ML, Mikulich-Gilbertson SK, Natvig C, Carrico JA, Lobato RL, Krause M, et al. Association between alcohol use disorder and hospital outcomes in colectomy patients - A retrospective cohort study. J Clin Anesth giugno. 2022;78:110674. (PMID: <searchLink fieldCode="PM" term="%2210%2E1016%2Fj%2Ejclinane%2E2022%2E110674%22">10.1016/j.jclinane.2022.110674)</searchLink><br />Khan AMA, Soliman MAR, Quiceno E, Elbayomy AM, Malueg MD, Aguirre AO, et al. Association of alcohol use disorder and perioperative complications and adverse events after spinal fusion surgery during the in-hospital period: an analysis of the National Inpatient Sample Database. World Neurosurg [Internet]. 1 marzo 2025 [citato 27 maggio 2025];195:123677. Disponibile su: https://www.sciencedirect.com/science/article/pii/S1878875025000233.<br />Li R, Huddleston SJ, Prastein DJ. Alcohol use disorder is associated with a lower risk of in-hospital mortality in type A aortic dissection repair: a population-based study of National Inpatient Sample from 2015–2020. Alcohol Alcohol Oxf Oxf. 2024;59(5):agae061. (PMID: <searchLink fieldCode="PM" term="%2210%2E1093%2Falcalc%2Fagae061%22">10.1093/alcalc/agae061)</searchLink><br />National (Nationwide) Inpatient Sample (NIS) [Internet]. [citato 26 febbraio 2025]. Disponibile su: https://hcup-us.ahrq.gov/news/exhibit&#95;booth/nis&#95;brochure.jsp.<br />Di Bello F, Rodriguez Peñaranda N, Marmiroli A, Longoni M, Falkenbach F, Le Chi Q, et al. Robot-assisted versus open radical cystectomy: comparison of adverse in-hospital outcomes. J Surg Oncol. 2025;131(8):1651–60. (PMID: <searchLink fieldCode="PM" term="%2210%2E1002%2Fjso%2E2810840152714%22">10.1002/jso.2810840152714)</searchLink><br />Polverino F, Marmiroli A, Longoni M, Le QC, Falkenbach F, Nicolazzini M, et al. The effect of chronic liver disease on adverse in-hospital outcomes after radical cystectomy and ileal conduit urinary diversion. Ann Surg Oncol. 2025. https://doi.org/10.1245/s10434-025-18032-y . (PMID: <searchLink fieldCode="PM" term="%2210%2E1245%2Fs10434-025-18032-y41339563%22">10.1245/s10434-025-18032-y41339563)</searchLink><br />Di Bello F, Siech C, de Angelis M, Rodriguez Peñaranda N, Tian Z, Goyal JA, et al. Perioperative complications and in-hospital mortality in paraplegic radical cystectomy patients. Ann Surg Oncol. 2025;32(1):583–8. (PMID: <searchLink fieldCode="PM" term="%2210%2E1245%2Fs10434-024-16332-339377845%22">10.1245/s10434-024-16332-339377845)</searchLink><br />Mazzone E, Preisser F, Nazzani S, Tian Z, Zaffuto E, Gallina A, et al. The effect of age and comorbidities on early postoperative complications after radical cystectomy: a contemporary population-based analysis. J Geriatr Oncol. 2019;10(4):623–31. (PMID: <searchLink fieldCode="PM" term="%2210%2E1016%2Fj%2Ejgo%2E2019%2E04%2E01131010691%22">10.1016/j.jgo.2019.04.01131010691)</searchLink><br />Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–9. (PMID: <searchLink fieldCode="PM" term="%2210%2E1016%2F0895-4356%2892%2990133-81607900%22">10.1016/0895-4356(92)90133-81607900)</searchLink><br />Siech C, Baudo A, de Angelis M, Jannello LMI, Di Bello F, Goyal JA, et al. Perioperative complications and in-hospital mortality in radical cystectomy patients with heart-valve replacement. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2024;50(6):108297.<br />Rodriguez Peñaranda N, Falkenbach F, Marmiroli A, Longoni M, Le QC, Catanzaro C, et al. Contemporary rates and predictors of prolonged hospital stay after radical cystectomy: a population-based analysis. World J Urol. 2025;43(1):478. (PMID: <searchLink fieldCode="PM" term="%2210%2E1007%2Fs00345-025-05860-640778945%22">10.1007/s00345-025-05860-640778945)</searchLink><br />World Health Organization (WHO) [Internet]. [citato 28 maggio 2025]. Disponibile su: https://www.who.int/.<br />Schulz KF, Grimes DA. Case-control studies: research in reverse. Lancet Lond Engl. 2002;359(9304):431–4. (PMID: <searchLink fieldCode="PM" term="%2210%2E1016%2FS0140-6736%2802%2907605-5%22">10.1016/S0140-6736(02)07605-5)</searchLink><br />Desai RJ, Franklin JM. Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners. BMJ. 2019;367:l5657. (PMID: <searchLink fieldCode="PM" term="%2210%2E1136%2Fbmj%2El565731645336%22">10.1136/bmj.l565731645336)</searchLink><br />Lane O, Ambai V, Bakshi A, Potru S. Alcohol use disorder in the perioperative period: a summary and recommendations for anesthesiologists and pain physicians. Reg Anesth Pain Med. 2024;49(9):621–7. (PMID: <searchLink fieldCode="PM" term="%2210%2E1136%2Frapm-2023-10435438050177%22">10.1136/rapm-2023-10435438050177)</searchLink><br />Sander M, Neumann T, von Dossow V, Schönfeld H, Lau A, Eggers V, et al. Alcohol use disorder: risks in anesthesia and intensive care medicine. Internist. 2006;47(4):332, 334–332336. (PMID: <searchLink fieldCode="PM" term="%2216521004%22">16521004)</searchLink><br />Watzl B, Watson RR. Role of alcohol abuse in nutritional immunosuppression. J Nutr. 1992;122(3 Suppl):733–7. (PMID: <searchLink fieldCode="PM" term="%2210%2E1093%2Fjn%2F122%2Esuppl%26#95%3B3%2E7331542040%22">10.1093/jn/122.suppl&#95;3.7331542040)</searchLink><br />Jaan A, Razzak IA, Chaudhary AJ, Farooq U, Khan AM, Sheikh LF, et al. Malnutrition severity predicts clinical outcomes in alcoholic hepatitis: evidence from national data. J Am Nutr Assoc. 2025;44(1):22–8. (PMID: <searchLink fieldCode="PM" term="%2239073449%22">39073449)</searchLink><br />Lauridsen SV, Thomsen T, Jensen JB, Kallemose T, Schmidt Behrend M, Steffensen K, et al. Effect of a smoking and alcohol cessation intervention initiated shortly before radical cystectomy-The STOP-OP study: a randomised clinical trial. Eur Urol Focus. 2022;8(6):1650–8. (PMID: <searchLink fieldCode="PM" term="%2210%2E1016%2Fj%2Eeuf%2E2022%2E02%2E00535241394%22">10.1016/j.euf.2022.02.00535241394)</searchLink><br />Egholm JW, Pedersen B, Møller AM, Adami J, Juhl CB, Tønnesen H. Perioperative alcohol cessation intervention for postoperative complications. Cochrane Database Syst Rev. 2018;11(11):18343.<br />Morra S, Scheipner L, Baudo A, Jannello LMI, de Angelis M, Siech C, et al. Contemporary conditional cancer-specific survival rates in surgically treated nonmetastatic primary urethral carcinoma. J Surg Oncol. 2024;129(7):1348–53. (PMID: <searchLink fieldCode="PM" term="%2210%2E1002%2Fjso%2E2763738606531%22">10.1002/jso.2763738606531)</searchLink><br />Morra S, Scheipner L, Baudo A, Jannello LMI, de Angelis M, Siech C, et al. Unmarried status effect on stage at presentation and treatment patterns in primary urethral carcinoma patients. Urol Oncol. 2024;42(5):161.e17-161.e23. (PMID: <searchLink fieldCode="PM" term="%2210%2E1016%2Fj%2Eurolonc%2E2024%2E01%2E02238320935%22">10.1016/j.urolonc.2024.01.02238320935)</searchLink><br />Nicolazzini M, Longoni M, Falkenbach F, Marmiroli A, Le QC, Catanzaro C, et al. Extracorporeal vs. intracorporeal urinary diversion at robot-assisted radical cystectomy: adverse in-hospital outcomes. J Robot Surg. 2025;19(1):351. (PMID: <searchLink fieldCode="PM" term="%2210%2E1007%2Fs11701-025-02512-040616730%22">10.1007/s11701-025-02512-040616730)</searchLink><br />Di Bello F, Rodriguez Peñaranda N, Marmiroli A, Longoni M, Falkenbach F, Le QC, et al. Total hospital cost of robot-assisted approach in major urological cancer surgeries. Minerva Urol Nephrol. 2025;77(2):217–25. (PMID: <searchLink fieldCode="PM" term="%2210%2E23736%2FS2724-6051%2E25%2E06282-240298347%22">10.23736/S2724-6051.25.06282-240298347)</searchLink><br />Rodriguez Peñaranda N, di Bello F, Marmiroli A, Falkenbach F, Longoni M, Le QC, et al. Urinary diversion versus adverse in-hospital outcomes after radical cystectomy. Ann Surg Oncol. 2025;32(3):2233–40. (PMID: <searchLink fieldCode="PM" term="%2210%2E1245%2Fs10434-024-16644-439656392%22">10.1245/s10434-024-16644-439656392)</searchLink> – Name: SubjectMinor Label: Contributed Indexing Group: Data: <i>Keywords: </i>Alcohol use disorder; Complications; Cystectomy; NIS; Urinary bladder cancer – Name: DateEntry Label: Entry Date(s) Group: Date Data: <i>Date Created: </i>20260112 <i>Date Completed: </i>20260626 <i>Latest Revision: </i>20260626 – Name: DateUpdate Label: Update Code Group: Date Data: 20260626 – Name: DOI Label: DOI Group: ID Data: 10.1245/s10434-025-19018-6 – Name: AN Label: PMID Group: ID Data: 41524880 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cmedm&AN=41524880 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1245/s10434-025-19018-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 5847 Subjects: – SubjectFull: Length of Stay statistics & numerical data Type: general – SubjectFull: Humans Type: general – SubjectFull: Female Type: general – SubjectFull: Male Type: general – SubjectFull: Hospital Mortality Type: general – SubjectFull: Aged Type: general – SubjectFull: Middle Aged Type: general – SubjectFull: Prognosis Type: general – SubjectFull: Survival Rate Type: general – SubjectFull: Follow-Up Studies Type: general – SubjectFull: Cystectomy adverse effects Type: general – SubjectFull: Cystectomy mortality Type: general – SubjectFull: Urinary Diversion adverse effects Type: general – SubjectFull: Urinary Diversion mortality Type: general – SubjectFull: Urinary Bladder Neoplasms surgery Type: general – SubjectFull: Urinary Bladder Neoplasms pathology Type: general – SubjectFull: Postoperative Complications etiology Type: general – SubjectFull: Alcoholism complications Type: general Titles: – TitleFull: Alcohol Use Disorder versus Adverse In-Hospital Outcomes after Radical Cystectomy and Ileal Conduit Urinary Diversion. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Polverino F – PersonEntity: Name: NameFull: Catanzaro C – PersonEntity: Name: NameFull: Nicolazzini M – PersonEntity: Name: NameFull: Petix M – PersonEntity: Name: NameFull: Quarta L – PersonEntity: Name: NameFull: Filzmayer M – PersonEntity: Name: NameFull: Goyal JA – PersonEntity: Name: NameFull: Morra S – PersonEntity: Name: NameFull: Califano G – PersonEntity: Name: NameFull: Collà Ruvolo C – PersonEntity: Name: NameFull: La Rocca R – PersonEntity: Name: NameFull: Briganti A – PersonEntity: Name: NameFull: Chun FKH – PersonEntity: Name: NameFull: Palumbo C – PersonEntity: Name: NameFull: Schiavina R – PersonEntity: Name: NameFull: Musi G – PersonEntity: Name: NameFull: Shariat SF – PersonEntity: Name: NameFull: Saad F – PersonEntity: Name: NameFull: Longo N – PersonEntity: Name: NameFull: Karakiewicz PI IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1534-4681 Numbering: – Type: volume Value: 33 – Type: issue Value: 6 Titles: – TitleFull: Annals of surgical oncology Type: main |
| ResultId | 1 |